AB

Amalgamated Bank Portfolio holdings

AUM $13B
1-Year Return 23.92%
This Quarter Return
+4.43%
1 Year Return
+23.92%
3 Year Return
+105.94%
5 Year Return
+196.1%
10 Year Return
+496.3%
AUM
$11.7B
AUM Growth
+$47.5M
Cap. Flow
-$239M
Cap. Flow %
-2.04%
Top 10 Hldgs %
29.94%
Holding
3,186
New
220
Increased
615
Reduced
1,382
Closed
176

Sector Composition

1 Technology 30.29%
2 Financials 12.6%
3 Healthcare 11.24%
4 Consumer Discretionary 11.08%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AMRC icon
1976
Ameresco
AMRC
$1.44B
$31K ﹤0.01%
1,088
BBSI icon
1977
Barrett Business Services
BBSI
$1.2B
$31K ﹤0.01%
936
CRGY icon
1978
Crescent Energy
CRGY
$2.21B
$31K ﹤0.01%
2,631
FSLY icon
1979
Fastly
FSLY
$1.14B
$31K ﹤0.01%
4,160
GNK icon
1980
Genco Shipping & Trading
GNK
$774M
$31K ﹤0.01%
1,439
+154
+12% +$3.32K
SLNO icon
1981
Soleno Therapeutics
SLNO
$2.85B
$31K ﹤0.01%
+761
New +$31K
SRCE icon
1982
1st Source
SRCE
$1.55B
$31K ﹤0.01%
583
TPC
1983
Tutor Perini Corporation
TPC
$3.37B
$31K ﹤0.01%
1,420
DOLE icon
1984
Dole
DOLE
$1.3B
$30K ﹤0.01%
2,413
NAT icon
1985
Nordic American Tanker
NAT
$669M
$30K ﹤0.01%
7,478
ARHS icon
1986
Arhaus
ARHS
$1.52B
$30K ﹤0.01%
+1,773
New +$30K
PGRE
1987
Paramount Group
PGRE
$1.57B
$30K ﹤0.01%
6,410
PRTA icon
1988
Prothena Corp
PRTA
$442M
$30K ﹤0.01%
1,440
SBOW
1989
DELISTED
SilverBow Resources, Inc.
SBOW
$30K ﹤0.01%
797
+77
+11% +$2.9K
CECO icon
1990
Ceco Environmental
CECO
$1.7B
$29K ﹤0.01%
1,001
DAWN icon
1991
Day One Biopharmaceuticals
DAWN
$729M
$29K ﹤0.01%
2,138
FA icon
1992
First Advantage
FA
$2.75B
$29K ﹤0.01%
1,811
FDMT icon
1993
4D Molecular Therapeutics
FDMT
$318M
$29K ﹤0.01%
1,363
FIP icon
1994
FTAI Infrastructure
FIP
$518M
$29K ﹤0.01%
3,337
GBTG icon
1995
American Express Global Business Travel
GBTG
$4.32B
$29K ﹤0.01%
4,342
+3,254
+299% +$21.7K
GRC icon
1996
Gorman-Rupp
GRC
$1.13B
$29K ﹤0.01%
782
IBRX icon
1997
ImmunityBio
IBRX
$2.46B
$29K ﹤0.01%
4,523
LMND icon
1998
Lemonade
LMND
$3.88B
$29K ﹤0.01%
1,781
+123
+7% +$2K
NMRA icon
1999
Neumora Therapeutics
NMRA
$262M
$29K ﹤0.01%
2,910
+2,402
+473% +$23.9K
PUBM icon
2000
PubMatic
PUBM
$376M
$29K ﹤0.01%
1,448